Eavesdropping on brain cell chatter
Wednesday, April 16, 2014 · Posted by NIH/National Institute of Neurological Disorders and Stroke
Findings suggest that astrocytes in the mossy fiber system may act as a switch that reacts to large amounts of neuronal activity by raising their levels of calcium. These calcium increases occur over multiple seconds, a relatively long time period compared to that seen in neurons. The spatial extent of the astrocyte calcium increases was also relatively large in comparison to the size of the synapse.
A new cell type is implicated in epilepsy caused by traumatic brain injury
Tuesday, March 11, 2014 · Posted by Tufts University
A new study in mice identifies increased levels of a specific neurotransmitter as a contributing factor connecting traumatic brain injury (TBI) to post-traumatic epilepsy. The findings suggest that damage to brain cells called interneurons disrupts neurotransmitter levels and plays a role in the development of epilepsy after a traumatic brain injury.
Signal found to enhance survival of new brain cells
Monday, November 11, 2013 · Posted by Johns Hopkins Medicine
A specialized type of brain cell that tamps down stem cell activity ironically, perhaps, encourages the survival of the stem cells’ progeny, Johns Hopkins researchers report. Understanding how these new brain cells “decide” whether to live or die and how to behave is of special interest because changes in their activity are linked to neurodegenerative diseases.
Stem cell transplant restores memory, learning in mice
Sunday, April 21, 2013 · Posted by University of Wisconsin-Madison
For the first time, human embryonic stem cells have been transformed into nerve cells that helped mice regain the ability to learn and remember.
A study at the University of Wisconsin-Madison is the first to show that human stem cells can successfully implant themselves in the brain and then heal neurological deficits, says senior author Su-Chun Zhang, a professor of neuroscience and neurology.
A promising clinical trial to reduce the severity of autistic disorders
Tuesday, December 11, 2012 · Posted by Instituts thématiques
Sixty children between 3 and 11 years old with autism or Aspergers syndrome were treated for 3 months either with a diuretic to reduce their intracellular chloride levels or with a placebo. Although this therapy is not curative, it nevertheless reduced the autistic disorders severity in three-quarters of the children. The researchers have filed a request for authorisation to perform a multi-centre European clinical trial in order to determine more precisely the population concerned by this therapy.